glp-1 concerns Part 2 of a 3-Part Series; Medications for Weight Loss FDA warns about unapproved GLP-1

In de jaren 70 en 80 begon men het te gebruiken als supplement ter ondersteuning van fysieke uithoudingsvermogen, vetverbranding en herstel bij sporters

doi: 10.1002/sim.5705 48 AbadiASaadatSYavariPBajdikCJaliliP

1 in 2 adults will be obese by 2030 (www.nejm.com) 1 in 4 adults will be severely obese by 2030 (www.nejm.com) Prevalence of diabetes (Type 1 and Type 2) will increase by 54% from 35M people in 2015 to 54M people in 2030 (www.nih.gov) Growth in percentage of population with obesity and severe obesity from 1999-2018: On the Positive Side The American Medical Association has recognized obesity as a "chronic disease" because it can be the underlying cause of other medical conditions, such as heart disease, diabetes, and even some cancers

Over time, this effect on blood sugar is also supposed to have an effect on fat lipid levels and triglyceride levels

The result: a cheeky boost to your sex drive

Some people on semaglutide notice an increased heart rate and palpitations, episodes that can be distressing if they recur